Related references
Note: Only part of the references are listed.ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
Na Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
Dali Han et al.
NATURE (2019)
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
CANCER Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response
Rajarsi Mandal et al.
SCIENCE (2019)
Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
Huamin Wang et al.
NATURE COMMUNICATIONS (2019)
Regulation of Gene Expression by N6-methyladenosine in Cancer
Jun Liu et al.
TRENDS IN CELL BIOLOGY (2019)
m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
Seungwon Yang et al.
NATURE COMMUNICATIONS (2019)
Association of N6-methyladenosine with viruses and related diseases
Fang Wu et al.
VIROLOGY JOURNAL (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Atlas of quantitative single-base-resolution N6-methyl-adenine methylomes
Casslynn W. Q. Koh et al.
NATURE COMMUNICATIONS (2019)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
RNA N-6-methyladenosine modification in cancers: current status and perspectives
Xiaolan Deng et al.
CELL RESEARCH (2018)
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification
Hengyou Weng et al.
CELL STEM CELL (2018)
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2
Mengnuo Chen et al.
HEPATOLOGY (2018)
IRF1 supports DNA binding of STAT1 by promoting its phosphorylation
Kosuke Zenke et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
The m6A Reader ECT2 Controls Trichome Morphology by Affecting mRNA Stability in Arabidopsis[OPEN]
Lian-Huan Wei et al.
PLANT CELL (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flavia Castro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Chemical Modifications in the Life of an mRNA Transcript
Sigrid Nachtergaele et al.
ANNUAL REVIEW OF GENETICS, VOL 52 (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1)
Marcin Kowanetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cross-talk among writers, readers, and erasers of m(6)A regulates cancer growth and progression
Subbarayalu Panneerdoss et al.
SCIENCE ADVANCES (2018)
NUPR1 maintains autolysosomal efflux by activating SNAP25 transcription in cancer cells
Yanchao Mu et al.
AUTOPHAGY (2018)
METTL14 Suppresses the Metastatic Potential of Hepatocellular Carcinoma by Modulating N6-Methyladenosine- Dependent Primary MicroRNA Processing
Jin-Zhao Ma et al.
HEPATOLOGY (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
Isaia Barbieri et al.
NATURE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
Ly P. Vu et al.
NATURE MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
Qi Cui et al.
CELL REPORTS (2017)
Emerging links between m6A and misregulated mRNA methylation in cancer
Samie R. Jaffrey et al.
GENOME MEDICINE (2017)
Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation
Ruta Veinalde et al.
ONCOIMMUNOLOGY (2017)
Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis
Phillip J. Hsu et al.
CELL RESEARCH (2017)
Cytoplasmic m6A reader YTHDF3 promotes mRNA translation
Ang Li et al.
CELL RESEARCH (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
Vishwajith Sridharan et al.
BRITISH JOURNAL OF CANCER (2016)
Dynamics of Human and Viral RNA Methylation during Zika Virus Infection
Gianluigi Lichinchi et al.
CELL HOST & MICROBE (2016)
Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing
Wen Xiao et al.
MOLECULAR CELL (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells
Gianluigi Lichinchi et al.
NATURE MICROBIOLOGY (2016)
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Xiao Wang et al.
CELL (2015)
RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation
Yanan Yue et al.
GENES & DEVELOPMENT (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Nicolas J. Llosa et al.
CANCER DISCOVERY (2015)
Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase
Xiao-Li Ping et al.
CELL RESEARCH (2014)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Jianzhao Liu et al.
NATURE CHEMICAL BIOLOGY (2014)
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers
Yuan Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
KiBem Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Guanqun Zheng et al.
MOLECULAR CELL (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
Kate D. Meyer et al.
CELL (2012)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Guifang Jia et al.
NATURE CHEMICAL BIOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI
Vanessa Deschoolmeester et al.
CANCER MICROENVIRONMENT (2011)
Regulation of the expression of inducible nitric oxide synthase
Andrea Pautz et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2010)
High IFN-γ production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4)
Pushpa Pandiyan et al.
JOURNAL OF IMMUNOLOGY (2007)
CXC chemokine ligand 9/monokine induced by IFN-γ production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors
Anton V. Gorbachev et al.
JOURNAL OF IMMUNOLOGY (2007)
Type I inteferon gene induction by the interferon regulatory factor family of transcription factors
Kenya Honda et al.
IMMUNITY (2006)
HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-γ and tumor necrosis factor-α
M Lichterfeld et al.
BLOOD (2004)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Complex roles of Stat1 in regulating gene expression
CV Ramana et al.
ONCOGENE (2000)
Share Paper
